{
  "id": "drip_score",
  "title": "Drug Resistance in Pneumonia (DRIP) Score",
  "description": "Predicts risk for community-acquired pneumonia due to drug-resistant pathogens (CAP-DRP). Helps determine when broad-spectrum antibiotics should be used to ensure effective treatment while avoiding unnecessary antibiotic resistance.",
  "category": "infectious_disease",
  "version": "2013",
  "parameters": [
    {
      "name": "antibiotic_use_60_days",
      "type": "string",
      "required": true,
      "description": "Antibiotic use within 60 days (Major risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "long_term_care_facility",
      "type": "string",
      "required": true,
      "description": "Residence in a long-term-care facility (Major risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "tube_feeding",
      "type": "string",
      "required": true,
      "description": "Tube feeding (Major risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "prior_drug_resistant_infection",
      "type": "string",
      "required": true,
      "description": "Prior infection with a drug-resistant pathogen (Major risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "chronic_pulmonary_disease",
      "type": "string",
      "required": true,
      "description": "Chronic pulmonary disease (Minor risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "hospitalization_60_days",
      "type": "string",
      "required": true,
      "description": "Prior hospitalization within 60 days (Minor risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "poor_functional_status",
      "type": "string",
      "required": true,
      "description": "Poor functional status (Minor risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "mrsa_colonization",
      "type": "string",
      "required": true,
      "description": "MRSA colonization (Minor risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "wound_care",
      "type": "string",
      "required": true,
      "description": "Wound care (Minor risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "gastric_acid_suppression",
      "type": "string",
      "required": true,
      "description": "Gastric acid suppression (Minor risk factor)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    }
  ],
  "result": {
    "name": "drip_score",
    "type": "integer",
    "unit": "points",
    "description": "DRIP score total (0-14 points)"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 3,
        "stage": "Low Risk",
        "description": "Low risk of drug-resistant pneumonia",
        "interpretation": "Scores <4 were associated with lower risk of drug-resistant pneumonia. Consider treating without extended-spectrum antibiotics. Standard empirical antibiotics appropriate."
      },
      {
        "min": 4,
        "max": 14,
        "stage": "High Risk",
        "description": "High risk of drug-resistant pneumonia",
        "interpretation": "Scores ≥4 were associated with higher risk of drug-resistant pneumonia. Extended-spectrum antibiotic coverage is recommended to ensure effective treatment."
      }
    ]
  },
  "references": [
    "Webb BJ, Dascomb K, Stenehjem E, Dean N. Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score. Antimicrob Agents Chemother. 2016;60(5):2652-63. doi: 10.1128/AAC.03071-15.",
    "Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J. 2011;38(4):878-87. doi: 10.1183/09031936.00141110.",
    "Webb BJ, Dangerfield B, Pasha JS, et al. Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. Respir Med. 2012;106(11):1606-12. doi: 10.1016/j.rmed.2012.08.010."
  ],
  "formula": "Major risk factors (2 points each): Antibiotic use within 60 days, Long-term care facility residence, Tube feeding, Prior drug-resistant infection. Minor risk factors (1 point each): Chronic pulmonary disease, Hospitalization within 60 days, Poor functional status, MRSA colonization, Wound care, Gastric acid suppression. Total: 0-14 points.",
  "notes": [
    "The DRIP score should only be used for bacterial causes of pneumonia.",
    "At threshold ≥4 points: Sensitivity 0.82, Specificity 0.81, PPV 0.68, NPV 0.90.",
    "DRIP score is more predictive than healthcare-associated pneumonia (HCAP) criteria for drug-resistant pathogens.",
    "May decrease antibiotic overutilization by 46% compared to HCAP criteria.",
    "False negatives may occur with MRSA, P. aeruginosa, severe COPD, IV drug use, psychiatric illness, and homelessness.",
    "False positives may occur with S. pneumoniae and methicillin-susceptible S. aureus (MSSA).",
    "Local validation and institutional antibiotic resistance patterns should be considered for optimal implementation."
  ]
}